Product Information
ENALAPRIL 1 MG/ML ORAL SOLN is a generic product labeled by Aurobindo Pharma Limited, priced at $0.7946 per ML under NDC 59651052955. Its NADAC has been published 92 times since Jan 1, 2025.
FDA first approved this application on Jan 8, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
59651052955
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ENALAPRIL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA216458FDA Approved
1/8/2024
TE Code
AB
On Market Since
1/8/2024
Pharmacological Classes
Price Statistics
The NADAC for ENALAPRIL 1 MG/ML ORAL SOLN has been published 92 times since Jan 1, 2025, and over the history we have for it it has declined 40.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7946 per ML |
|---|---|
| All-time high | $1.3301 (Jan 15, 2025) |
| All-time low | $0.7946 (Sep 23, 2026) |
| 52-week high | $1.1387 |
| 52-week low | $0.7946 |
| Median price | $1.0975 |
| Average price | $1.0957 |
| Largest weekly change | +10.4% (May 21, 2025) |
| Weeks tracked | 92 |
| Tracking since | Jan 1, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ENALAPRIL MALEATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ENALAPRIL MALEATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENALAPRIL 1 MG/ML ORAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL 1 MG/ML ORAL SOLN, manufactured by Aurobindo Pharma Limited, is $0.7946 per ML (NDC 59651052955), effective Sep 30, 2026.
How has the price of ENALAPRIL 1 MG/ML ORAL SOLN changed over time?
Over the history we have for it, the NADAC for ENALAPRIL 1 MG/ML ORAL SOLN has declined 40.3%. It has been tracked across 92 weekly CMS publications since Jan 1, 2025.
What are the highest and lowest recorded NADAC prices for ENALAPRIL 1 MG/ML ORAL SOLN?
Since Jan 1, 2025, the NADAC for ENALAPRIL 1 MG/ML ORAL SOLN has ranged from a low of $0.7946 (Sep 23, 2026) to a high of $1.3301 (Jan 15, 2025), with a median of $1.0975 per ML.
Are there cheaper alternatives to ENALAPRIL 1 MG/ML ORAL SOLN?
No other NADAC-published product currently shares the active ingredient and strength of ENALAPRIL 1 MG/ML ORAL SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ENALAPRIL 1 MG/ML ORAL SOLN?
ENALAPRIL 1 MG/ML ORAL SOLN (NDC 59651052955) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.